Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ALGORAE PHARMACEUTICALS LIMITED Director's Dealing 2018

Aug 30, 2018

64249_rns_2018-08-30_4da894f3-3f0d-4fc2-8513-d7a75aa12520.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3X Initial Director’s Interest Notice

Rule 3.19A.1

Appendix 3X

Initial Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Introduced 30/9/2001.

Name of entity LIVING CELL TECHNOLOGIES LIMITED
ABN 14 104 028 042

We (the entity) give ASX the following information under listing rule 3.19A.1 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Ken Taylor
Date of appointment 31 August 2018

Part 1 - Director’s relevant interests in securities of which the director is the registered holder In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Number & class of securities Expiry Date01-Jul-2001-Jul-2101-Jul-2001-Jul-2104-May-1904-May-1901-Jul-19
Unlisted options Exercise Price Expiry Date
250,000 $0.100 01-Jul-20
250,000 $0.100 01-Jul-21
100,000 $0.140 01-Jul-20
100,000 $0.190 01-Jul-21
400,000 $0.075 04-May-19
400,000 $0.100 04-May-19
600,000 $0.113 01-Jul-19
Total 2,100,000
  • See chapter 19 for defined terms.

Appendix 3X Page 1

11/3/2002

Appendix 3X Initial Director’s Interest Notice

Part 2 – Director’s relevant interests in securities of which the director is not the registered holder In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

==> picture [401 x 159] intentionally omitted <==

----- Start of picture text ----- Name of holder & nature of interest Number & class of SecuritiesNote: Provide details of thecircumstances giving rise to the Nilrelevant interest.----- End of picture text -----

Part 3 – Director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract N/A
Nature of interest N/A
Name of registered holder(if issued securities) N/A
No. and class of securities to whichinterest relates N/A
  • See chapter 19 for defined terms.

Appendix 3X Page 2

11/3/2002